TransMedics Group, Inc. ( TMDX) - Key Metrics
TMDX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $4.70 | $3.08 | $1.01 | $0.56 |
| 2025Q3 | $4.22 | $0.71 | $2.04 | $1.82 |
| 2025Q2 | $4.64 | $1.03 | $2.70 | $2.43 |
| 2025Q1 | $4.26 | $0.76 | -$0.08 | -$0.89 |
TMDX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 9.88 |
| 2025Q3 | ? | 39.35 |
| 2025Q2 | ? | 32.55 |
| 2025Q1 | ? | 22.09 |
TMDX
Price: $75.48
52 week price:
Earnings Per Share: 4.37 USD
P/E Ratio: 14.71
Exchange: NGM
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 513900
Market Capitalization: 2.4 billion